Connect your AI

DBV Technologies DBVT Book value per share

Book value per share at other companies

Avalo TherapeuticsAVTX

$3.40-70.9%

Cullinan Therapeutics, Inc.CGEM

$10.76-1.9%

Celldex TherapeuticsCLDX

$6.85-35.3%

Nektar TherapeuticsNKTR

$23.29+2,285%

Kymera TherapeuticsKYMR

$15.79+60.9%

Alumis Inc.ALMS

$4.53+46.2%

Other financials

Income statement

Revenue$900.0K+12.5%

Operating income-$47.9M-80.1%

Net income-$47.6M-75.6%

EPS (diluted)-$0.11+57.7%

Balance sheet

Cash & equivalents$229.2M+1,668%

Total debt$6.1M-15.7%

Total equity$207.9M+7,069%

Total assets$266.4M+427%

Cash flow

Operating cash flow-$49.1M-149%

CapEx$400.0K—

Free cash flow-$49.5M-151%

Valuation

Market cap$923.31M+269%

Enterprise value$700.21M+188%

P/S159.6×+89.0×

Profitability

Operating margin-2,910.4%-265pp

Net margin-2,895.4%-257pp

FCF margin-2,619.5%+69.9pp

Returns & leverage

Return on equity-158.9%-26.4pp

Debt / equity0×-2.5×

Current ratio4.8×+4.0×

Where this comes from

Calculated from DBV Technologies’s reported figures.

total stockholders equity/weighted shares diluted=$0.49

Based on the most recent quarter.

The official record: DBV Technologies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about DBV Technologies's book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is DBV Technologies's book value per share?: DBV Technologies (DBVT) reported book value per share of $0.49 in Q1 2026.
How has DBV Technologies's book value per share changed year-over-year?: DBV Technologies's book value per share increased by 1615.2% year-over-year, from $0.03 to $0.49.
What is the long-term trend for DBV Technologies's book value per share?: Over 5 years (2020 to 2025), DBV Technologies's book value per share has grown at a -20.5% compound annual growth rate (CAGR), from $3.80 to $1.21.
What does book value per share mean?: Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.